1 |
Cheng H, Wang P, Wang N, Dong W, Chen Z, Wu M, Wang Z, Yu Z, Guan D, Wang L, Zhao R. Neuroprotection of NRF2 against Ferroptosis after Traumatic Brain Injury in Mice. Antioxidants 2023;12:731. [DOI: 10.3390/antiox12030731] [Reference Citation Analysis]
|
2 |
Lu Q, Lu X, Zhang Y, Huang W, Zhou H, Li T. Recent advances in ferroptosis and therapeutic strategies for glioblastoma. Front Mol Biosci 2022;9:1068437. [PMID: 36710875 DOI: 10.3389/fmolb.2022.1068437] [Reference Citation Analysis]
|
3 |
Miska J, Chandel NS. Targeting fatty acid metabolism in glioblastoma. J Clin Invest 2023;133. [PMID: 36594473 DOI: 10.1172/JCI163448] [Reference Citation Analysis]
|
4 |
Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 2023;66:100916. [PMID: 36610291 DOI: 10.1016/j.drup.2022.100916] [Reference Citation Analysis]
|
5 |
Chi H, Li B, Wang Q, Gao Z, Feng B, Xue H, Li G. Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. Front Oncol 2023;13:1065994. [PMID: 36937406 DOI: 10.3389/fonc.2023.1065994] [Reference Citation Analysis]
|